发明名称 |
Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof |
摘要 |
Disclosed is a composition comprising recombinant iduronate-2-sulfatase (IDS). The glycosylation pattern and formylglycine content of the IDS composition are different from those of Elaprase and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome. |
申请公布号 |
US9206402(B2) |
申请公布日期 |
2015.12.08 |
申请号 |
US201214128918 |
申请日期 |
2012.06.15 |
申请人 |
GREEN CROSS CORPORATION;MediGeneBio Corporation |
发明人 |
Jin Thong-Gyu;Chung Yo Kyung;Paik Sang Hoon;Park Yoo Chang;Seo Jinwook;Choi Yong Woon;Son Jong Mun;Kim Yong-Chul |
分类号 |
C12N9/16;A61K38/46 |
主分类号 |
C12N9/16 |
代理机构 |
Sughrue Mion, PLLC |
代理人 |
Sughrue Mion, PLLC |
主权项 |
1. A composition comprising, as an active ingredient, an iduronate-2-sulfatase (IDS) having the amino acid sequence of SEQ ID NO: 1, wherein a cysteine residue at position 59 in the IDS amino acid sequence is converted into formylglycine (FGly) at a molar ratio of 65% or higher. |
地址 |
Yongin-si KR |